Upharmacia digest. dec 2015

Ukrainian Pharmaceutical Market Monthly
Upharmacia
Macroeconomic Environment | Market &
Companies News | Regulatory Updates |
Healthcare News
Issue: 12 2015
UPharma Consulting is a consulting company, operating in the healthcare and pharma sectors. Our
clients - pharmaceutical companies, pharmacy chains, distributors, investment funds, banks, and
other stakeholders in the healthcare sector.
UPharma Consulting, Kiev
www.upharma-c.com / mailbox@upharma-c.com

Ukrainian Pharmaceutical Market Monthly: December 2015
MACROECONOMIC ENVIRONMENT
Description of the indicators:
Macroeconomic Indicators
GDP (Gross Domestic Product) is an aggregate measure of production equal to the sum of the gross
values added of all resident, institutional units engaged in production (plus any taxes, and minus
any subsidies, on products not included in the value of their outputs) calculated in current prices.
Converted from UAH to USD in accordance with an average official NBU exchange rate in the
corresponding period. Hereinafter: excluding the temporarily occupied territory of the Autonomous
Republic of Crimea and City of Sevastopol, as well as the part of zone of the antiterrorist operation.
Source: State Statistics Service of Ukraine.
Export of goods is a sale of goods by Ukrainian subjects of foreign economic activities to foreign
subjects of foreign economic activities (including non-cash payment) with or without exportation
of these goods through the customs border of Ukraine, including the re-export of goods. Initially
calculated in USD. Source: State Statistics Service of Ukraine.
Import of goods is a purchase (including non-cash payment) of goods by Ukrainian subjects of foreign
economic activities in foreign subjects of economic activities with or without the importation of these
goods into the territory of Ukraine, including the purchase of goods for domestic consumption by
establishments and organizations of Ukraine located abroad. Initially calculated in USD. Source: State
Statistics Service of Ukraine.
Industrial production sales is the value of industrial goods, which are actually shipped in the period, as
indicated in documents decorated as the basis for calculating with the buyer (customer), regardless of
income payments for them. Converted from UAH to USD in accordance with an average official NBU
exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Retail turnover of enterprises is the value of consumer goods sold via retail trade and restaurants to
the population by all operating enterprises. It also includes direct retail sales by industrial, transport
and other non-trade enterprises. In addition, retail turnover includes retail sales of food products to
departments, organizations and enterprises to provide meals to the people they serve (at sanatoria,
children’s care institutions, hospitals, etc.). Reflected in current prices. Converted from UAH to USD
in accordance with an average official NBU exchange rate in the corresponding period. Source: State
Unemployment rate is a ratio (percent) of the unemployed registered at the State Employment Service
to the average annual population of working age. Source: State Statistics Service of Ukraine.
Average salary is an average value of remuneration in cash and in kind paid to employees for time
worked or work done. Converted from UAH to USD in accordance with an average official NBU
exchange rate in the corresponding period. Source: State Statistics Service of Ukraine.
Official currency exchange rate is the rate established by the National Bank of Ukraine under which
Ukrainian national currency – UAH (Ukrainian hryvnia) will be exchanged for foreign currency (USD or
EUR). Calculated as average value in the corresponding period. Source: National Bank of Ukraine.
Pharmaceutical Industry Indicators
Export of pharma products is an export of goods related to the group “Pharmaceutical products” under
the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in USD.
Import of pharma products is an import of goods related to the group “Pharmaceutical products” under
the Ukrainian Classification of Goods for Foreign Economic Activities. Initially calculated in USD.
Pharma retail sales are retail sales of different product categories of “pharmacy basket” (drugs,
medical devices, cosmetics and food supplements) in values and volumes. Converted from UAH to
USD in accordance with an average official NBU exchange rate in the corresponding period. Source:
Morion.
WACP (Weighted average cost of a pack) is a ratio of pharma retail sales in values to pharma retail
sales in volumes.
CPI (Consumer price index) is an indicator of changes at the time of prices and tariffs for commodities
and services being purchased by the population for unproductive consumption calculated to
corresponding month of previous year. Source: State Statistics Service of Ukraine.
Pharma products CPI is a Consumer price index of “Pharmaceutical products, medical products,
appliances and equipment” group calculated to corresponding month of previous year. Source: State
Local companies share is the share (percent) of sales related to Ukrainian companies in overall pharma
retail sales in values and volumes. Source: Morion
Table: Key macroeconomic
indicators in Ukraine (Jan-Nov 2015)
2015
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
MACROECONOMIC INDICATORS
Q1 Q2 Q3
GDP (bn USD) 17.353 20.795 25.552
GDP growth, % y-o-y -51% -35% -26%
Export of goods (bn USD) 2.98 2.99 3.45 3.07 2.94 3.09 3.15 3.09 3.35 3.23 3.13
Export growth, % y-o-y -32% -37% -32% -39% -41% -30% -34% -22% -22% -23% -21%
Import of goods (bn USD) 3.01 2.86 3.17 2.86 2.63 2.76 2.98 3.88 3.24 3.22 3.07
Import growth, % y-o-y -34% -41% -35% -38% -46% -37% -34% -2% -30% -27% -27%
Industrial production sales (bn USD) 6.01 4.56 5.51 5.91 5.65 5.79 5.71 5.42 5.72 6.29 5.92
Industrial production growth, % y-o-y -41% -54% -45% -33% -38% -35% -33% -23% -20% -21% -19%
Retail turnover of enterprises (bn USD) 1.97 1.44 1.61 1.66 1.94 1.83 1.94 1.88 1.86 2.04 1.80
Retail turnover growth, % y-o-y -50% -61% -56% -40% -35% -38% -41% -32% -38% -31% -33%
Unemployment rate 2.0 2.0 1.9 1.8 1.8 1.7 1.6 1.6 1.5 1.5 1.6
Average salary (USD) 218 148 166 176 193 202 202 194 199 207 193
OFFICIAL CURRENCY EXCHANGE RATE
UAH/USD 15.8 24.5 23.3 22.7 20.9 21.2 21.8 21.6 21.8 21.8 23.31
UAH/EUR 18.5 27.8 25.3 24.5 23.3 23.8 23.9 24.0 24.5 24.6 25.07
PHARMACEUTI CAL INDUSTRY INDICATORS
Export of pharma products (mio USD) 11.79 12.05 13.37 13.46 13.00 15.36 13.85 9.01 13.79 12.2 11.7
Pharma Export growth, % y-o-y -1% -42% -50% -44% -39% -39% -6% -54% -47% -37% -52%
Import of pharma products (mio USD) 90.2 114.5 103.3 103.7 84.2 115.0 106.5 93.3 121.1 147.14 141.25
Pharma Import growth, % y-o-y -49% -47% -67% -36% -60% -44% -47% -47% -31% -28% -24%
Pharma retail sales, values (mio USD) 239.8 177.0 197.6 180.0 193.0 177.7 172.6 177.1 193.2 206.3 196.6
Retail sales in values growth, % y-o-y -41% -54% -47% -40% -28% -29% -32% -24% -28% -26% -20%
Pharma retail trade, volumes (mio units) 132.4 143.9 141.5 122.6 124.5 118.4 119.5 122.5 126.7 130.2 129.0
Retail sales in volumes growth, % y-o-y -21% -15% -21% -20% -11% -9% -10% -8% -11% -5% -4%
WACP, USD 1.95 1.81 1.24 1.41 1.47 1.52 1.48 1.45 1.52 1.58 1.52
WACP growth, % y-o-y -21% -22% -40% -27% -23% -21% -23% -18% -19% -22% -18%
CPI of Ukraine 128.5 134.5 145.8 160.9 158.4 157.5 155.3 152.8 151.9 146.4 138.1
Pharma products CPI 149.2 155.5 170.3 164.7 159.5 153.5 151.8 149.4 145.8 142.1 146.6
Local companies share, values, % 38.7 38.5 39.6 40.7 41.5 41.7 41.8 41.4 41.4 41.4 41.7
Local companies share, volumes, % 74.9 75.2 77.1 77.6 77.6 77.9 78.4 78.2 76.5 75.7 75.8

KEY ECONOMIC EVENTS
»» On Dec 25, the 2016 Draft Budget and the Tax Code were approved by the Ukrainian parliament. The compromise
version of the Tax Code foresees the cut of payroll tax from 37% to 20%, decrease of personal income tax from
18% to 15%, enterprise profit tax and VAT are to remain unchanged, 17% and 20% respectively. Preference VAT
rate for drugs is also to maintain its reduced rate of over 7%.
»» The 2016 Budget deficit is projected at 3.7% of GDP, with UAH 601.4 bn revenues. Spending cuts targeted
education and healthcare, while increases were earmarked for the army, police and housing.
»» Ukraine PM indicated seven main tasks for Ukraine in 2016, which are: reforming secondary school education,
reforming health care, conducting privatization of state enterprises, implementing tax reform, extending
decentralization, fulfilling the EU free trade area and implementing the EU visa-free regime. These goals were
agreed with the American Chamber of Commerce in Ukraine, Mr. Yatsenyuk said.
»» The IMF mission made a decision to change its landing policy in Ukraine’s favor, meaning it will continue provision
of tranches to Ukraine, despite its Russian USD 3 bn Eurobond debt. The Russian officials did not approved the
decision, saying Russia is willing to defend its interests in court.
»» The date of the next IMF tranche arrival is still uncertain as its officials still need to study Ukraine’s Budget,
the Minister of Finance said. Despite the Budget submitted to the parliament met all IMF requirements, it is still
unclear how the IMF will evaluate the amendments made to it, Mrs. Jaresko stated.
»» Industrial production fell 4.9% y-o-y in Nov, with slight improvement in machinery production (4% y-o-y). Lugansk
region showed 61% y-o-y surplus in production growing. Sales of industrial production fell 19% y-o-y in Nov.
»» Agreement between Ukraine and the EU on the deep and comprehensive free trade zone is to enter into force
since Jan 1, 2016. The agreement will eliminate 97% tariffs on Ukrainian goods and reduce the average tariff on
Ukrainian exports from 7.6% to 0.5%. Subsequently, since Jan 2, 2016, Ukraine exits the free trade zone with
Russia and reduces duties on all Russian products.
»» Ukraine’s Economy Ministry introduced the embargo of some Russian goods to be in force since Jan 10, 2016,
as a response to Russia’s cancelation of its free trade area with Ukraine and imposition of embargo on Ukrainian
agriculture and food products. Ukraine’s embargo will relate to Russian food and beverages, some detergents,
fertilizers and plant protectors, railway equipment and diesel locomotives.
239.8
177.0
197.6
180.0
193.0
177.7
172.6
177.1
193.2
206.3
196.6
132.4
143.9
141.5
122.6
124.5
118.4
119.5
122.5
126.7
130.2 129.0
100
110
120
130
140
150
160
100
120
140
160
180
200
220
240
260
Pharma retail sales
Values (mio USD) & Volumes (mio units)
Jan-Nov 2015
mio USD mio units
11.79 12.05
13.37 13.46 13.00
15.36
13.85
9.01
13.75
12.20
11.70
90.2
114.5
103.4 103.7
84.3
115.0
106.6
93.3
122.2
147.1
141.25
20
40
60
80
100
120
140
160
0
2
4
6
8
10
12
14
16
18
Ukrainian Internation trade in pharma
production
Export & Import, mio USD
Jan-Nov 2015
Export Import
6.01
4.56
5.51
5.91
5.65 5.80 5.71
5.43
5.72
6.29
5.92
1.97
1.44 1.61 1.66
1.94
1.83
1.94 1.88 1.86
2.04
1.80
0.0
0.5
1.0
1.5
2.0
2.5
3.0
0
1
2
3
4
5
6
7
Industrial production sales &
Retail turnover of enterprises surplus
Jan-Nov 2015, bn USD
Industrial production sales Retail turnover of enterprises
15.81
24.48
23.26 22.71
20.92 21.23 21.76 21.63 21.78 21.84
23.31
19.26
28.95 29.52
26.92
25.48 24.91
26.09 25.91 26.14
24.56 25.07128.5
134.5 145.8
160.9 158.4 157.5 155.3 152.8 151.9
146.4 146.6
0
20
40
60
80
100
120
140
160
180
0
5
10
15
20
25
30
35
OFFICIAL CURRENCY EXCHANGE RATE
+Consumer Price Index
Jan-Nov 2015
UAH/USD UAH/EUR CPI of Ukraine

MARKET & COMPANIES NEWS
Pharmaceuticals and medicine are
among the most perspective fields
in Ukraine for foreign investors
In the nearest future,
pharmaceutical industry and
medicine are to be among TOP-5
industries, foreign investors will
consider as the most attractive
ones, “Economic truth” publication
states. Last year the capital
investments in pharmaceutical
companies increased by 19.7%
y-o-y.
Foreign investors note the
presence of qualified staff
potential, relatively unoccupied
market and government programs
to support businesses in the
pharmaceutical field, “Concorde
capital” investment company
director Igor Mazepa said. They
also deem Ukrainian production
capacities have considerable
potential for extension being
able to produce a wide range of
products according to the latest
world standards.
“Arterium”
is developing
drugs for military and emergency
medicine
“Arterium corp.” started
development of drugs, which
could be used is military and
emergency medicine considered
as perspective. As the
development stage could take
3-4 years, the company does not
forecast an approximate date of
the drugs launching.
After the company’s hemostatic
drug Tramix (tranexamic acid)
had been launched in late 2014,
its sales were estimated at 9 ths.
of units, in volumes. “Arterium’s”
drugs are actively used in the
antiterrorist operation zone, as
the company gratuitously supplies
preparation to the needs of
military hospitals, “Arterium’s”
officials stated.
“Arterium corp.” is the 4th
company on Ukrainian
pharmaceutical market, portfolio
of which consists of 148 generic
and several original drugs in 11 of
14 ATC groups.
GlaxoSmithKline
is creating the
CIS cluster
GlaxoSmithKline announced
that since January 1, 2016, the
company’s representatives in
Azerbaijan, Georgia, Kazakhstan
and Middle Asia (Uzbekistan and
Kirgizstan) are subordinated to
Regional general Director of GSK
in Ukraine and BMA (Belarus,
Moldova, Armenia) Serkan
Yagcioglu.
Therefore, the new CIS cluster
will be created in MENA/CIS
(Middle East, North Africa and
CIS) region, witch gives the
opportunities for mutual support
between the offices in the
countries included.
As the markets of Azerbaijan,
Georgia, Kazakhstan and Middle
Asia have similar dynamics,
including them into new cluster
with Ukraine and BMA will make
the operating model more simple
and clear, Senior Vice President
of GSK and Director of MENA/
CIS region Fabio Landazabal
commented.
General Director in Turkey,
Azerbaijan and Georgia Emin
Fadillioglu will be responsible for
Turley only since 2016.
“Borshchahivskiy
CPP” has
launched new antiallergic drug
Ukrainian 7th biggest company
“Borschagovsky CPP” launched
antiallegric drug Alerdez
(desloratadine) to cure nasal
allergy and urticaria such as
itching and rashes.
“BCPP” is a 16th company on
Ukrainian pharmaceutical market
as of 9M2015. It has improved its
position form 19th place PPG. The
company is basically specialized in
cardio drugs, while preparations
for respiratory system take about
7% in its portfolio.
“Darnitsa” is
allowed to buy a
share of “Borshchahivskiy CPP”
Antimonopoly Committee of
Ukraine has allowed “Darnitsa”
pharmaceutical company to
acquire more than 25% of
shares of “Borshchahivskiy
CPP”. Previously, on March
20, 2015, Financial Company
“Kub”, representing “Darnitsa’s”
interests, acquired 29.95% of
shares of “BCPP” on the auction
for UAH 171.8 mio. After the
auction “Darnitsa” announced that
it intends to promote the goals
and policies of the “BCPP”.
Experts expect that “Darnitsa”
associates with “BCPP” in the
medium term, which could lead
to increase of competition on the
Ukrainian pharmaceutical market.
“Darnitsa” was the third company
on the market as of 2014 and is
expected to improve its position
in 2015 rating. In 2015, the
company’s officials confirmed
they want to integrate “BCPP” and
“Kiev Vitamin Factory” into the
“Darnitsa’s” structure, as it used
to be until 1994.

REGULATORY UPDATES
On Dec 10, the Draft Law of
Ukraine “On Amendments to
certain legislative acts of Ukraine
on legislation improvement
on healthcare” regarding the
autonomization of healthcare
establishments was registered
in the Ukrainian parliament. The
Draft Law is an alternative to the
projects submitted by the Cabinet
of Ministers of Ukraine dated
07.07.2015 and by the Deputy
Oleg Musiy dated 17.07.2015.
After on Sept 16 the Parliament
Healthcare Committee sent the
alternative Draft Law back for
revision, the new improved one
was approved by Deputies.
The Draft Law defines the
legal forms of healthcare
establishments, sources of
financing of medical care
provision, requirements to
constituent documents, as
well as simplifies the order
of reorganizing of healthcare
establishments, etc. Unlike the
previous versions, the Draft
Law foresees state, municipal
and private forms of ownership
healthcare establishments could
have. Private establishments are
not limited in the choice of legal
and organizational form.
The Draft Law also indicates that
all healthcare establishments
could use funds raised from
entities and individuals and to set
fees for medical services based
on the method of calculation of
the cost of medical services.
Therefore, under the Draft Law
the funds are now be managed
by healthcare establishments
themselves.
--
On Dec 31, the Order #764 of the
MOH “On Amendments to the list
of goods, which pharmacies and
their structural units have a right
to purchase and sell” dated Nov
23, 2015 has entered into force.
The assortment of goods
pharmacies can purchase and sell
included following positions:
»» instruments, devices for oral,
skin, nails and hair care;
»» items and means for
aromatherapy (aroma lamps,
oil sticks, candles);
»» products of cotton wool
(cotton swabs, discs,
plates) feminine care
means, adhesives, paper
handkerchiefs, paper and
wet wipes, toilet paper, paper
towels, hosiery knitwear,
packaging materials, which
are not registered as medical
products;
»» tools, devices and other
products to combat addictions;
»» laboratory glassware,
pharmacy scales;
»» capacities of thermal insulation
material to maintain the
temperature during transport
(cold boxes, thermo bag,
thermo boxes), ice packs,
card-indicators, termo testers
freeze indicators;
It is expected that the
amendments approved will
contribute to the sale of actual
goods, including for people living
in rural areas; and also improve
the efficiency of the pharmacies’
activity through increased sales
volumes.
--
On Dec 9, the European Business
Association sent an open letter
to the members of the Parliament
Healthcare Committee regarding
the combined version of the
Draft Law of Ukraine “On Drugs”
being announced for propositions
on Nov 26. According to the
Ukrainian business community,
the new combined version of
two Draft Laws (#2162 dated
Feb 15, 2015 and #2162-1 dated
Mar 2, 2015) needs a thorough
processing regarding following
issues:
»» formulation of terms “State
control over the quality of
drugs” and “Regulation of
clinical trials” to not give the
opportunities for corruption
abuses;
»» compliance of certain
provisions with Directive
2001/83/EU of the European
Parliament and of the
European Council dated
November 6, 2001;
»» use of unspecified references
to some International
regulations;
»» the lack of consideration of the
current conditions the market
is working in and no provision
of appropriate transitional
periods, which is a standard
practice for the EU;
»» absence of the provisions
aimed at deregulation of the
pharmaceutical market to have
a positive impact regarding the
accessibility quality, effective
and safe medicines in Ukraine.
--
On Dec 23, the Resolution of
the Cabinet of Ministers of
Ukraine (the CMU) #1144 “On
Amendments to the Resolution
of the CMU #73 dated Mar 5,
2015” regarding pilot-project of
state regulation of insulin prices
was issued. According to the
Resolution, since Apr 1, 2016,
insulin preparations turnover
and their reimbursement at
the expense of local budgets, is
carried out at the reference prices
(reimbursement prices) after such
preparations are enlisted in the
register of reference prices in due
course.
Additionally, the MOH is assigned
to approve the Regulation on
registry of patients requiring
insulin and until Feb 1, 2016,
and bring it into force until Apr

1, 2016. The MOH also has to
compile and promulgate the
register of reference prices on
insulin preparations until Apr 1,
2016 and by Mar 1, to submit the
Draft Act on insulin preparations
reimbursement since Apr 1, 2016.
--
Under the Resolution #1024 “On
Approval of provision standard of
inpatient hospital beds per 10 ths
of population” dated Nov 25, the
Cabinet of Ministers of Ukraine
has decreased the standard
number of hospital beds per 10
ths of population from 80 to 60.
The MOH will need to develop
the methodology of provision
of hospital beds to population,
under which the Regional State
administrations shrink the
number of hospital beds. Since
1999, the standard number of
hospital beds in Ukraine was 80
per 10 ths of population.
HEALTHCARE NEWS
The compromise Tax Code is
to maintain 7% VAT on the
pharmaceuticals
The Draft Code registered by
the Ministry of Finance provides
a preference 7% VAT rate on
pharmaceutical production.
Thereby, the Ministry heeded
the pharmaceutical community
stating expected 20% VAT rate
on pharmaceuticals, will lead
to significant cuts in revenues
and make foreign companies to
leave Ukrainian market. It is also
proposed to increase the VAT
registration threshold to UAH 2
mio.
The Government cut healthcare
expenditures in 2016
The 2016 Budget provides
UAH 44 bn expenditures on
healthcare, which is UAH 2 bn
less than year before. About 99%
of the funds are to be allocated
to local budgets. UAH 13.2 bn
are to be spend on the MOH
system funding. Additionally,
the PM of Ukraine recognized
the failure in health care reform
and considered the stabilization
of prices as a main task for
the government in 2016. Mr.
Yatsenyuk deems the stabilization
of prices and increase of social
standards are to compensate
difficulties caused by the increase
of tariffs.
The Minister of Healthcare of
Ukraine made conclusions on the
work made in 2015
At the special conference on Dec
21, Alexander Kvitashvili stated
that in 2015 the MOH achieved
significant changes in reforming
the pharmaceutical market
in terms of provision of the
population with quality medicines
and vaccines, established
legislative foundations for a new
state policy aimed at changing the
functioning of medical institutions
and fair financing system,
improvement of health services
and started a formation of a new
system of public health. The MOH
simplified the process of drugs
registration by reducing its role in
the registration procedures, the
Deputy Minister of Healthcare
Olexandra Pavlenko said. A
unified National Drugs list was
also created in 2015; as well new
licensing conditions of economic
activity in the area of medical
practice were introduced. Another
achievement was creation of the
Register of insulin-dependent
patients under the reimbursement
system implementation since
2016.
Another important reform was
a change in public procurement
system and start of cooperation
with International organizations
in this field. In public healthcare
field, the MOH achieved the
creation of the Center of
Public Health, resumption of
construction of a new medical-
diagnostic complex of children
hospital “OKHMATDYT”, and
managed to promptly and
systematically respond to the
challenge of polio outbreak in
Ukraine.
The MOH Head also indicated
priorities for 2016:
»» modernization of primary
healthcare and improvement of
work conditions for physicians;
»» creation of modern operational
and dispatching departments
in the centers of emergency
medical care and catastrophe
medicine in most regions of
Ukraine;
»» transfer of 100% of the funds

for drugs to International
organizations to ensure
uninterrupted provision of
population with medicines and
vaccines;
»» implementation of the insulin
reimbursement system for
patients with diabetes;
»» change of activity mechanisms
for state and municipal
healthcare institutions towards
their autonomization through
the adoption of appropriate
Laws;
»» implementation of guaranteed
package of medical services
to be financed from the state
budget
»» provision of valuable work
of the Centre of Public
Health, which is responsible
for disease prevention and
surveillance in the country;
»» completion of the new building
of the children’s hospital
“OKHMATDYT”;
»» developing of approaches to
reform the system of doctors
graduate and postgraduate
training.
A. Kvitashvili said he is not going
to leave his post
The Minister of Healthcare of
Ukraine Alexander Kvitashvili
said he is not going to leave his
post, even after the Ukrainian
Parliament failed to endorse his
dismissal four times since his
appointment in Dec 2014. In Jul
2015, Mr. Kvitashvili wrote a
resignation latter, hoping it would
help to approve the healthcare
reform legislation the MOH had
been fostering, but his work did
not change since then. “I came
to Ukraine to work, having an
experience of practical changes
in Georgia, that is why, if I do not
have a support I should have,
it would be logical to leave,” the
Minister said. “But now something
has changed and some support
has appeared.”
Mr. Kvitashvili also said he does
not know anything about possible
appointment of Deputy Oleksiy
Honcharenko to the post of the
Minister of Healthcare.
The World Bank will lend Ukraine
$170 mio to support primary
medicine
Ukraine will receive $170 mio
for primary medicine equipment
procurement, the Deputy Minister
of Healthcare of Ukraine Igor
Pereginets stated. “Primary
medicine system improvement
is among the main goals in
healthcare reformation,” Mr.
Pereginets said. “The MOH will
increase financing of primary
care in regions and villages up
to 35% and in cities of regional
importance up to 20-25%. The
World Bank’s project will help us
to procure necessary medical
equipment for this aid.”
The World Bank is also going to
allocate $215 mio during next
5 years to finance Ukrainian
healthcare system.

Upharmacia digest. dec 2015

More Related Content

What's hot

Viewers also liked

Similar to Upharmacia digest. dec 2015

Recently uploaded

Upharmacia digest. dec 2015